{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:24:50Z","timestamp":1794230690038,"version":"4.9.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vaccine.2024.06.021","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T21:45:29Z","timestamp":1718919929000},"page":"126053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7697-0084","authenticated-orcid":false,"given":"Lauren","family":"Pischel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalle","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cacesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahder","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolambi","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noureen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavin M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa A.","family":"Grimshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amyn A.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Goshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.021_b0005","unstructured":"World Health Organization. International health regulations (2005). Third edition ed: World Health Organization; 2016."},{"key":"10.1016\/j.vaccine.2024.06.021_b0010","unstructured":"WHO Director-General's statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox - 23 July 2022 [Internet]. World Health Organization. 2022. [Accessed June 2, 2024]. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022."},{"key":"10.1016\/j.vaccine.2024.06.021_b0015","unstructured":"Mpox (Monkeypox) Outbreak 2022-24 Mpox (Monkeypox) Outbreak: Global Trends [Internet]. 2024 [Accessed June 2nd, 2024]. Available from: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/."},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2024.06.021_b0020","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","article-title":"The eradication of smallpox\u2013an overview of the past, present, and future","volume":"29","author":"Henderson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.021_b0025","first-page":"13","article-title":"Smallpox and biological warfare: a disease revisited","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.vaccine.2024.06.021_b0030","unstructured":"JYNNEOS \u2014 Approval Histroy, Letters, Review, and Related Documents \u2014 JYNNEOS [Internet]. 2021 [Accessed July 28, 2022]. Available from: https:\/\/www.fda.gov\/media\/131869\/download."},{"key":"10.1016\/j.vaccine.2024.06.021_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.vaccine.2024.06.021_b0040","first-page":"1","article-title":"Prevention and treatment of monkeypox","author":"Rizk","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2024.06.021_b0045","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 Efficacy trial of modified vaccinia ankara as a vaccine against smallpox","volume":"381","author":"Pittman","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0050","unstructured":"Clinical Review Memo, September 19, 2019 - JYNNEOS [Internet]. 2019 [Accessed August 8, 2022]. Available from: https:\/\/www.fda.gov\/media\/131870\/download."},{"key":"10.1016\/j.vaccine.2024.06.021_b0055","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID, World Health O. Smallpox and its eradication \/ F. Fenner ... [et al.]. Geneva: World Health Organization; 1988."},{"key":"10.1016\/j.vaccine.2024.06.021_b0060","unstructured":"Fact sheet for healthcare providers administering vaccine: emergency use authorization of JYNNEOS (smallpox and monkeypox vaccine, live, non-replicating) for prevention of monkeypox disease in individuals determined to be at high risk for monkeypox infection. [Internet]. 2022 [Accessed January 13, 2024]. Available from: https:\/\/www.fda.gov\/media\/160774\/download."},{"key":"10.1016\/j.vaccine.2024.06.021_b0065","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.06.021_b0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10654-019-00576-5","article-title":"A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research","volume":"35","author":"Muka","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.06.021_b0075","unstructured":"Haddaway NH, Grainger MJ, Gray CT. (2022) citationchaser: An R package and Shiny app for forward and backward citations chasing in academic searching. Zenodo. Version 0.0.3."},{"key":"10.1016\/j.vaccine.2024.06.021_b0080","unstructured":"Reference Deduplicator. [Internet]. 2021. [Acessed January 6, 2024]. Available from: https:\/\/library.medicine.yale.edu\/reference-deduplicator."},{"key":"10.1016\/j.vaccine.2024.06.021_b0085","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. [Accessed January 6, 2024]. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.vaccine.2024.06.021_b0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","article-title":"Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022","volume":"11","author":"Wu","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.06.021_b0100","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2024.06.021_b0105","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2022."},{"key":"10.1016\/j.vaccine.2024.06.021_b0110","unstructured":"RStudio Team. RStudio: Integrated Development Environment for R. Boston, MA: RStudio, PBC; 2020."},{"key":"10.1016\/j.vaccine.2024.06.021_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.vaccine.2024.06.021_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2024.06.021_b0125","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1056\/NEJMc2309583","article-title":"Vaccine Effectiveness against Mpox in the United States","volume":"389","author":"Arbel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0130","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.34.2300442","article-title":"Authors' response: Bias in the vaccine effectiveness estimates of one-dose post-exposure prophylaxis against mpox","volume":"28","author":"Montero Morales","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.06.021_b0135","article-title":"Outbreak of monkeypox in the Canary Islands from may 15 to june 6, 2022","volume":"97","author":"Garc\u00eda-Hern\u00e1ndez","year":"2023","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.vaccine.2024.06.021_b0140","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2022.18320","article-title":"Human monkeypox virus infection in the immediate period after receiving modified vaccinia ankara vaccine","volume":"328","author":"Hazra","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.06.021_b0145","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200882","article-title":"Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022","volume":"27","author":"Merad","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.06.021_b0150","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMc2211944","article-title":"Breakthrough Infections after Postexposure Vaccination against Mpox","volume":"387","author":"Thy","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0155","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.24.2200883","article-title":"Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022","volume":"28","author":"Montero Morales","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.06.021_b0160","article-title":"Effectiveness of MVA-BN vaccination in a population at high-risk of mpox: a Spanish cohort study","author":"Font\u00e1n-Vela","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2023.12.066","article-title":"JYNNEOS\u2122 effectiveness as post-exposure prophylaxis against mpox: challenges using real-world outbreak data","author":"Rosen","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.021_b0170","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(23)00057-9","article-title":"Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study","volume":"23","author":"Bertran","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0175","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing Mpox: a Multijurisdictional case-control study - United States, August 19, 2022-March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.021_b0180","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against Mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0185","doi-asserted-by":"crossref","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.021_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2023.101093","article-title":"Characteristics of confirmed mpox cases among clinical suspects: a prospective single-centre study in Belgium during the 2022 outbreak","volume":"52","author":"Hens","year":"2023","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.vaccine.2024.06.021_b0195","doi-asserted-by":"crossref","unstructured":"Payne AB, Ray LC, Cole MM, Canning M, Houck K, Shah HJ, et al. (2022) Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022. MMWR Morb Mortal Wkly Rep. 71:1560-4.","DOI":"10.15585\/mmwr.mm7149a5"},{"key":"10.1016\/j.vaccine.2024.06.021_b0200","doi-asserted-by":"crossref","unstructured":"Payne AB, Ray LC, Kugeler KJ, Fothergill A, White EB, Canning M, et al. (2022) Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving \u22651 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022. MMWR Morb Mortal Wkly Rep. 71:1278-82.","DOI":"10.15585\/mmwr.mm7140e3"},{"key":"10.1016\/j.vaccine.2024.06.021_b0205","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","article-title":"Real-world effectiveness of a single dose of mpox vaccine in males","volume":"29","author":"Wolff Sagy","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0210","unstructured":"IMPACT OF VACCINATION ON MPOX INCIDENCE IN MSM ON PrEP IN THE ANRS 174 DOXYVAC TRIAL [Internet]. 2023 [Accessed June 7, 2023]. Available from: https:\/\/www.croiconference.org\/abstract\/impact-of-vaccination-on-mpox-incidence-in-msm-on-prep-in-the-anrs-174-doxyvac-trial\/."},{"key":"10.1016\/j.vaccine.2024.06.021_b0215","article-title":"Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk","author":"Brousseau","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0220","doi-asserted-by":"crossref","unstructured":"Ramchandani MS, Berzkalns A, Cannon CA, Dombrowski JC, Brown E, Chow EJ, et al. (2023) Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington. Open Forum Infect Dis. 10:ofad528.","DOI":"10.1093\/ofid\/ofad528"},{"key":"10.1016\/j.vaccine.2024.06.021_b0225","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3201\/eid2905.221797","article-title":"Mpox among public festival attendees, chicago, illinois, USA, July-August 2022","volume":"29","author":"Faherty","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0230","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1038\/s41467-023-40490-9","article-title":"Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain","volume":"14","author":"Agust\u00ed","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.06.021_b0235","doi-asserted-by":"crossref","first-page":"992","DOI":"10.15585\/mmwr.mm7236a4","article-title":"Reduced odds of mpox-associated hospitalization among persons who received JYNNEOS vaccine - California, May 2022-May 2023","volume":"72","author":"Schildhauer","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.021_b0240","doi-asserted-by":"crossref","first-page":"893","DOI":"10.15585\/mmwr.mm7233a3","article-title":"Epidemiologic and clinical features of Mpox in Adults Aged >50 Years - United States, May 2022-May 2023","volume":"72","author":"Eustaquio","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.021_b0245","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0250","doi-asserted-by":"crossref","unstructured":"Farrar JL, Lewis NM, Houck K, Canning M, Fothergill A, Payne AB, et al. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1610-5.","DOI":"10.15585\/mmwr.mm715152a2"},{"key":"10.1016\/j.vaccine.2024.06.021_b0255","article-title":"Resurgence of symptomatic Mpox among vaccinated patients: first clues from a new-onset local cluster","volume":"53","author":"Jamard","year":"2023","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.vaccine.2024.06.021_b0260","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s15010-023-01997-x","article-title":"Mpox outbreak 2022: an overview of all cases reported to the cologne health department","volume":"51","author":"Kr\u00f6ger","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2024.06.021_b0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1473-3099(23)00492-9","article-title":"Mpox in people with past infection or a complete vaccination course: a global case series","volume":"24","author":"Hazra","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0270","doi-asserted-by":"crossref","first-page":"696","DOI":"10.15585\/mmwr.mm7225a6","article-title":"Notes from the field: emergence of an mpox cluster primarily affecting persons previously vaccinated against mpox - chicago, illinois, March 18-June 12, 2023","volume":"72","author":"Faherty","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.021_b0275","first-page":"12","article-title":"Epidemiological and clinical characteristics of patients admitted to a secondary hospital with suspected MPOX virus infection: Is HIV playing a role?","author":"Est\u00e9vez","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0280","doi-asserted-by":"crossref","unstructured":"Candela C, Raccagni AR, Bruzzesi E, Bertoni C, Rizzo A, Gagliardi G, et al. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics. Viruses. 2023;15.","DOI":"10.3390\/v15030667"},{"key":"10.1016\/j.vaccine.2024.06.021_b0285","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.ajt.2023.07.016","article-title":"Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: a multicenter case series and literature review","volume":"23","author":"Higgins","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2024.06.021_b0290","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1216064","article-title":"Diverse sources of C. difficile infection identified on whole-genome sequencing","volume":"369","author":"Eyre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.021_b0295","doi-asserted-by":"crossref","first-page":"460","DOI":"10.15585\/mmwr.mm7320a3","article-title":"Monkeypox virus infections after 2 preexposure doses of JYNNEOS vaccine - United States, May 2022-May 2024","volume":"73","author":"Guagliardo","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.021_b0300","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1038\/s41467-024-48180-w","article-title":"Predicting vaccine effectiveness for mpox","volume":"15","author":"Berry","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.06.021_b0305","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1016\/j.vaccine.2023.10.013","article-title":"Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022","volume":"41","author":"van Ewijk","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.021_b0310","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3201\/eid2904.221622","article-title":"Serial interval and incubation period estimates of monkeypox virus infection in 12 jurisdictions, United States, May-August 2022","volume":"29","author":"Madewell","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0315","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3201\/eid3001.231164","article-title":"Clade I-associated Mpox cases associated with sexual contact, the democratic republic of the congo","volume":"30","author":"Kibungu","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0320","first-page":"465","article-title":"Human monkeypox: secondary attack rates","volume":"66","author":"Jezek","year":"1988","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.06.021_b0325","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.021_b0330","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.06.021_b0335","unstructured":"Mpox Caused by Human-to-Human Transmission of Monkeypox Virus with Geographic Spread in the Democratic Republic of the Congo [Internet]. 2023 [Accessed January 13, 2024]. Available from: https:\/\/emergency.cdc.gov\/han\/2023\/han00501.asp."},{"key":"10.1016\/j.vaccine.2024.06.021_b0340","unstructured":"Mpox (monkeypox) - Democratic Republic of the Congo; 23 November 2023 [Internet]. Disease Outbreak News. 2023. [Acessed May 25, 2024]. Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON493."},{"key":"10.1016\/j.vaccine.2024.06.021_b0345","unstructured":"Monkeypox - Democratic Republic of the Congo; 1 October 2020 [Internet]. Disease Outbreak News. 2023. [Acessed January 6, 2024]. Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/monkeypox-democratic-republic-of-the-congo."},{"key":"10.1016\/j.vaccine.2024.06.021_b0350","unstructured":"JPRN-jRCT1031230137 Effectiveness of LC16 in Mpox Prevention Trial [Internet]. 2024 [Accessed May 25, 2024]. [Accessed May 25, 2024]. Available from: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-jRCT1031230137."},{"key":"10.1016\/j.vaccine.2024.06.021_b0355","unstructured":"Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization 11-13 March 2024 [Internet]. 2024 [Accessed May 25, 2024]. Available from: https:\/\/www.who.int\/publications\/m\/item\/highlights-from-the-meeting-of-the-strategic-advisory-group-of-experts-(sage)-on-immunization--11-13-march-2024."},{"key":"10.1016\/j.vaccine.2024.06.021_b0360","unstructured":"ACIP Evidence to Recommendations for Use of JYNNEOS (orthopoxvirus) Vaccine Booster Every 2 Years (Policy Question 3 [Internet]. 2022. [Acessed January 6, 2024]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/JYNNEOS-orthopoxvirus-booster-2yrs-etr.html."},{"key":"#cr-split#-10.1016\/j.vaccine.2024.06.021_b0365.1","unstructured":"Quinn C, Pathela P. (2024) Health Advisory #12: Updates on Mpox in New York City. New York City Department of Health and Mental Hygiene"},{"key":"#cr-split#-10.1016\/j.vaccine.2024.06.021_b0365.2","unstructured":"p. 12. [Accessed June 6, 2024]. Available from: https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/han\/advisory\/2024\/han-advisory-12-mpox.pdf."},{"key":"10.1016\/j.vaccine.2024.06.021_b0370","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.36.2200620","article-title":"A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022","volume":"27","author":"Vaughan","year":"2022","journal-title":"Euro Surveill."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T14:53:18Z","timestamp":1726152798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":75,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0264410X24006947"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126053"}}